SGPL1 and lung cancer: For example, the level of SPL mRNA expression is reduced in intestinal metastatic tumors (Oskouian et al., 2006) and the sensitivity of lung cancer cells to cisplatin and doxorubicin is increased by over-expression of SPL (Min et al., 2005).